Ignite Creation Date:
2025-12-24 @ 11:41 PM
Ignite Modification Date:
2026-03-09 @ 6:00 AM
Study NCT ID:
NCT03206151
Status:
COMPLETED
Last Update Posted:
2025-05-23
First Post:
2017-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
Sponsor:
Taizhou Mabtech Pharmaceutical Co.,Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
009mCRCIIIP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None